{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T19:19:26Z","timestamp":1784143166267,"version":"3.55.0"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T00:00:00Z","timestamp":1446595200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s11940-015-0380-3","type":"journal-article","created":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T04:34:03Z","timestamp":1446611643000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Evidence for the Importance of Vitamin D Status in Neurologic Conditions"],"prefix":"10.1007","volume":"17","author":[{"given":"Anusha K.","family":"Yeshokumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deanna","family":"Saylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Kornberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen M.","family":"Mowry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,4]]},"reference":[{"issue":"Suppl1","key":"380_CR1","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.1016\/j.psyneuen.2009.05.023","volume":"34","author":"DA Fernandes de Abreu","year":"2009","unstructured":"Fernandes de Abreu DA, Eyles D, F\u00e9ron F. Vitamin D, a neuro-immunomodulator: implications for neurodegenerative and autoimmune diseases. Psycho Neuro Endocrinol. 2009;34(Suppl1):S265\u201377.","journal-title":"Psycho Neuro Endocrinol"},{"key":"380_CR2","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0031-6997(24)01468-6","volume":"52","author":"E Falkenstein","year":"2000","unstructured":"Falkenstein E et al. Multiple actions of steroid hormones\u2014a focus on rapid, nongenomic effects. Pharmacol Rev. 2000;52:513\u201356.","journal-title":"Pharmacol Rev"},{"key":"380_CR3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1615\/CritRevEukarGeneExpr.v17.i1.30","volume":"17","author":"R Khanal","year":"2007","unstructured":"Khanal R, Nemere I. Membrane receptors for vitamin D metabolites. Crit Rev Eukaryot Gene Expr. 2007;17:31\u201347.","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"380_CR4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/nrc.10081","volume":"33","author":"R Burkert","year":"2003","unstructured":"Burkert R, McGrath J, Eyles D. Vitamin D receptor expression in the embryonic rat brain. Neurosci Res Commun. 2003;33:63\u201371.","journal-title":"Neurosci Res Commun"},{"key":"380_CR5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jchemneu.2004.08.006","volume":"29","author":"DW Eyles","year":"2005","unstructured":"Eyles DW et al. Distribution of the vitamin D receptor and 1\u03b1-hydroxylase in human brain. J Chem Neuroanat. 2005;29:21\u201330.","journal-title":"J Chem Neuroanat"},{"key":"380_CR6","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1038\/srep03395","volume":"5","author":"C Tohda","year":"2013","unstructured":"Tohda C et al. Diosgenin-induced cognitive enhancement in normal mice is mediated by 1,25D3-MARRS. Sci Rep. 2013;5:3395.","journal-title":"Sci Rep"},{"issue":"1","key":"380_CR7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/(SICI)1098-1136(200007)31:1<59::AID-GLIA60>3.0.CO;2-Y","volume":"31","author":"D Baas","year":"2000","unstructured":"Baas D et al. Rat oligodendrocytes express the vitamin D3 receptor and respond to 1,25-dihydroxyvitamin D3. Glia. 2000;31(1):59\u201368.","journal-title":"Glia"},{"key":"380_CR8","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0306-4522(03)00040-X","volume":"118","author":"D Eyles","year":"2003","unstructured":"Eyles D et al. Vitamin D3 and brain development. Neuroscience. 2003;118:641\u201353.","journal-title":"Neuroscience"},{"key":"380_CR9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.brainresbull.2004.12.007","volume":"65","author":"F Feron","year":"2005","unstructured":"Feron F et al. Developmental vitamin D3 deficiency alters the adult rat brain. Brain Res Bull. 2005;65:141\u20138.","journal-title":"Brain Res Bull"},{"key":"380_CR10","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.bbr.2007.09.032","volume":"187","author":"LR Harms","year":"2008","unstructured":"Harms LR et al. Developmental vitamin D deficiency alters adult behaviour in 129\/SvJ and C57BL\/6 J mice. Behav Brain Res. 2008;187:343\u201350.","journal-title":"Behav Brain Res"},{"issue":"2","key":"380_CR11","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.yexmp.2015.02.004","volume":"98","author":"HA Shirazi","year":"2015","unstructured":"Shirazi HA et al. 1,25-Dihydroxyvitamin D3 enhances neural stem cell proliferation and oligodendrocyte differentiation. Exp Mol Pathol. 2015;98(2):240\u20135.","journal-title":"Exp Mol Pathol"},{"key":"380_CR12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0304-3940(03)00303-3","volume":"343","author":"J Brown","year":"2003","unstructured":"Brown J et al. 1,25-Dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons. Neurosci Lett. 2003;343:139\u201343.","journal-title":"Neurosci Lett"},{"issue":"41","key":"380_CR13","doi-asserted-by":"crossref","first-page":"E4359","DOI":"10.1073\/pnas.1404477111","volume":"111","author":"CS Latimer","year":"2014","unstructured":"Latimer CS et al. Vitamin D prevents cognitive decline and enhances hippocampal synaptic function in aging rats. Proc Natl Acad Sci U S A. 2014;111(41):E4359\u201366.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"380_CR14","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0197-4580(98)00079-7","volume":"19","author":"PW Landfield","year":"1998","unstructured":"Landfield PW, Cadwallader-Neal L. Long-term treatment with calcitriol (1,25(OH)2 vit D3) retards a biomarker of hippocampal aging in rats. Neurobiol Aging. 1998;19(5):469\u201377.","journal-title":"Neurobiol Aging"},{"issue":"5","key":"380_CR15","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0028-3908(99)00255-5","volume":"39","author":"Y Wang","year":"2000","unstructured":"Wang Y et al. Vitamin D3 attenuates cortical infarction induced by middle cerebral arterial ligation in rats. Neuropharmacology. 2000;39(5):873\u201380.","journal-title":"Neuropharmacology"},{"issue":"5","key":"380_CR16","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1210\/en.2011-1783","volume":"153","author":"R Balden","year":"2012","unstructured":"Balden R, Selvamani A, Sohrabji F. Vitamin D deficiency exacerbates experimental stroke injury and dysregulates ischemia-induced inflammation in adult rats. Endocrinology. 2012;153(5):2420\u201335.","journal-title":"Endocrinology"},{"issue":"1","key":"380_CR17","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1523\/JNEUROSCI.21-01-00098.2001","volume":"21","author":"LD Brewer","year":"2001","unstructured":"Brewer LD et al. Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons. J Neurosci. 2001;21(1):98\u2013108.","journal-title":"J Neurosci"},{"issue":"2","key":"380_CR18","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0169-328X(96)00260-4","volume":"45","author":"E Garcion","year":"1997","unstructured":"Garcion E et al. 1,25-Dihydroxyvitamin D3 inhibits the expression of inducible nitric oxide synthase in rat central nervous system during experimental allergic encephalomyelitis. Brain Res Mol Brain Res. 1997;45(2):255\u201367.","journal-title":"Brain Res Mol Brain Res"},{"issue":"12","key":"380_CR19","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.imbio.2012.07.018","volume":"217","author":"H Korf","year":"2012","unstructured":"Korf H et al. 1,25-Dihydroxyvitamin D3 curtails the inflammatory and T cell stimulatory capacity of macrophages through an IL-10-dependent mechanism. Immunobiology. 2012;217(12):1292\u2013300. This article provided strong evidence for the anti-inflammatory effect of vitamin D on macrophages.","journal-title":"Immunobiology"},{"issue":"3","key":"380_CR20","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3233\/JAD-130416","volume":"36","author":"E Dursun","year":"2013","unstructured":"Dursun E, Gezen-AK D, Yilmazer S. A new mechanism for amyloid-b induction of iNOS: vitamin D-VDR pathway disruption. J Alzheimers Dis. 2013;36(3):459\u201374.","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"380_CR21","doi-asserted-by":"crossref","first-page":"397","DOI":"10.4196\/kjpp.2014.18.5.397","volume":"18","author":"J Hur","year":"2014","unstructured":"Hur J et al. Regulatory effect of 25-hydroxyvitamin D3 on nitric oxide production in activated microglia. Korean J Physiol Pharmacolx. 2014;18(5):397\u2013402.","journal-title":"Korean J Physiol Pharmacolx"},{"issue":"2","key":"380_CR22","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1046\/j.1471-4159.1999.0730859.x","volume":"73","author":"E Garcion","year":"1999","unstructured":"Garcion E et al. 1,25-Dihydroxyvitamin D3 regulates the synthesis of gamma-glutamyl transpeptidase and glutathione levels in rat primary astrocytes. J Neurochem. 1999;73(2):859\u201366.","journal-title":"J Neurochem"},{"issue":"3","key":"380_CR23","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/1097-4547(20001101)62:3<374::AID-JNR7>3.0.CO;2-7","volume":"62","author":"K Shinpo","year":"2000","unstructured":"Shinpo K et al. Effect of 1,25-dihydroxyvitamin D3 on cultured mesencephalic dopaminergic neurons to the combined toxicity caused by L-buthionine sulfoximine and 1-methyl-4-phenylpyridine. J Neurosci Res. 2000;62(3):374\u201382.","journal-title":"J Neurosci Res"},{"issue":"7","key":"380_CR24","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1177\/1533317511429321","volume":"26","author":"KV Lu\u2019o\u2019ng","year":"2011","unstructured":"Lu\u2019o\u2019ng KV, Nguyen LT. The beneficial role of vitamin D in Alzheimer\u2019s disease. Am J Alheimers Dis Other Demen. 2011;26(7):511\u201320.","journal-title":"Am J Alheimers Dis Other Demen"},{"issue":"21","key":"380_CR25","doi-asserted-by":"crossref","first-page":"7091","DOI":"10.1523\/JNEUROSCI.2711-13.2014","volume":"34","author":"MR Durk","year":"2014","unstructured":"Durk MR et al. 1,25-Dihydroxyvitamin D3 reduces cerebral amyloid-\u03b2 accumulation and improves cognition in mouse models of Alzheimer\u2019s disease. J Neurosci. 2014;34(21):7091\u2013101.","journal-title":"J Neurosci"},{"key":"380_CR26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000355462","volume":"13","author":"MO Grimm","year":"2014","unstructured":"Grimm MO et al. Impact of vitamin D on amyloid precursor protein processing and amyloid-\u03b2 peptid degradation in Alzheimer\u2019s disease. Neurodegener Dis. 2014;13:75\u201381.","journal-title":"Neurodegener Dis"},{"issue":"5","key":"380_CR27","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.neurobiolaging.2013.11.005","volume":"35","author":"W Camu","year":"2014","unstructured":"Camu W et al. Vitamin D confers protection to motoneurons and is a prognostic factor of amyotrophic lateral sclerosis. Neurobiol Aging. 2014;35(5):1198\u2013205.","journal-title":"Neurobiol Aging"},{"key":"380_CR28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0169-328X(95)00314-I","volume":"36","author":"E Puchacz","year":"1996","unstructured":"Puchacz E et al. Vitamin D increases expression of the tyrosine hydroxylase gene in adrenal medullary cells. Brain Res Mol Brain Res. 1996;36:193\u20136.","journal-title":"Brain Res Mol Brain Res"},{"key":"380_CR29","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/jnr.21878","volume":"87","author":"B Sanchez","year":"2009","unstructured":"Sanchez B et al. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum. J Neurosci Res. 2009;87:723\u201332.","journal-title":"J Neurosci Res"},{"issue":"6","key":"380_CR30","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3109\/00207454.2013.847836","volume":"124","author":"A Hollo","year":"2014","unstructured":"Hollo A, Clemens Z, Lakatos P. Epilepsy and vitamin D. Int J Neurosci. 2014;124(6):387\u201393.","journal-title":"Int J Neurosci"},{"key":"380_CR31","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2567.2011.03482.x","volume":"134","author":"M Rosa Di","year":"2011","unstructured":"Di Rosa M et al. Vitamin D3: a helpful immuno-modulator. Immunology. 2011;134:123\u201339.","journal-title":"Immunology"},{"key":"380_CR32","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nri2378","volume":"8","author":"JR Moro","year":"2008","unstructured":"Moro JR, Iwata M, von Andriano UH. Vitamin effects on the immune system, vitamins A and D take centre stage. Nat Rev Immunol. 2008;8:685\u201398.","journal-title":"Nat Rev Immunol"},{"key":"380_CR33","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/dmrr.1275","volume":"27","author":"GB Ferreira","year":"2011","unstructured":"Ferreira GB et al. 1,25-Dihydroxyvitamin D3 alters murine dendritic cell behaviour in vitro and in vivo. Diabetes Metab Res Rev. 2011;27:933\u201341.","journal-title":"Diabetes Metab Res Rev"},{"key":"380_CR34","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/cns.12071","volume":"19","author":"AS Farias","year":"2013","unstructured":"Farias AS et al. Vitamin D3 induces IDO(+) tolerogenic DCs and enhances treg, reducing the severity of EAE. CNS Neurosci Ther. 2013;19:269\u201377.","journal-title":"CNS Neurosci Ther"},{"key":"380_CR35","doi-asserted-by":"crossref","first-page":"5155","DOI":"10.4049\/jimmunol.1200786","volume":"189","author":"LE Jeffery","year":"2012","unstructured":"Jeffery LE et al. Availability of 25-hydroxyvitamin D3 to APCs controls the balance between regulatory and inflammatory T cell responses. J Immunol. 2012;189:5155\u201364.","journal-title":"J Immunol"},{"key":"380_CR36","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1172\/JCI115072","volume":"87","author":"JM Lemire","year":"1991","unstructured":"Lemire JM, Archer DC. 1,25-Dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J Clin Invest. 1991;87:1103\u20137.","journal-title":"J Clin Invest"},{"key":"380_CR37","doi-asserted-by":"crossref","first-page":"5276","DOI":"10.4049\/jimmunol.1101211","volume":"188","author":"SW Kang","year":"2012","unstructured":"Kang SW et al. 1,25-Dihydroxyvitamin D3 promotes FOXP3 expression via binding to vitamin D response elements in its conserved noncoding sequence region. J Immunol. 2012;188:5276\u201382. This article provided the first evidence of direct effect of vitamin D on T lymphoctyes.","journal-title":"J Immunol"},{"key":"380_CR38","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.4049\/jimmunol.179.3.1634","volume":"179","author":"S Chen","year":"2007","unstructured":"Chen S et al. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol. 2007;179:1634\u201347.","journal-title":"J Immunol"},{"issue":"3","key":"380_CR39","doi-asserted-by":"crossref","first-page":"e0122821","DOI":"10.1371\/journal.pone.0122821","volume":"10","author":"S Won","year":"2015","unstructured":"Won S et al. Vitamin D prevents hypoxia\/reoxygenation-induced blood-brain barrier disruption via vitamin D receptor-mediated NF-kB signaling pathways. PLoS One. 2015;10(3):e0122821.","journal-title":"PLoS One"},{"issue":"52","key":"380_CR40","doi-asserted-by":"crossref","first-page":"21101","DOI":"10.1073\/pnas.1306072110","volume":"110","author":"IV Grishkan","year":"2013","unstructured":"Grishkan IV et al. 1,25-Dihydroxyvitamin D3 selectively and reversibly impairs T helper-cell CNS localization. Proc Natl Acad Sci U S A. 2013;110(52):21101\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"380_CR41","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/NEN.0b013e31827f4fcc","volume":"72","author":"J Smolders","year":"2013","unstructured":"Smolders J et al. Expression of vitamin D receptor and metabolizing enzymes in multiple sclerosis-affected brain tissue. J Neuropathol Exp Neurol. 2013;72:91\u2013105.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"10","key":"380_CR42","doi-asserted-by":"crossref","first-page":"e26262","DOI":"10.1371\/journal.pone.0026262","volume":"6","author":"S Wergeland","year":"2011","unstructured":"Wergeland S et al. Dietary vitamin D3 supplements reduce demyelination in the cuprizone model. PLoS One. 2011;6(10):e26262.","journal-title":"PLoS One"},{"issue":"12","key":"380_CR43","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/apm.12281","volume":"122","author":"AE Nystad","year":"2014","unstructured":"Nystad AE et al. Effect of high-dose 1,25-dihydroxyvitamin D3 on remyelination in the cuprizone model. APMIS. 2014;122(12):1178\u201386.","journal-title":"APMIS"},{"issue":"5","key":"380_CR44","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jocn.2012.10.005","volume":"20","author":"S Hewer","year":"2013","unstructured":"Hewer S et al. Vitamin D and multiple sclerosis. J Clin Neurosci. 2013;20(5):634\u201341.","journal-title":"J Clin Neurosci"},{"issue":"4","key":"380_CR45","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1017\/S0029665100000768","volume":"59","author":"CE Hayes","year":"2000","unstructured":"Hayes CE. Vitamin D: a natural inhibitor of multiple sclerosis. Proc Nutr Soc. 2000;59(4):531\u20135.","journal-title":"Proc Nutr Soc"},{"issue":"8","key":"380_CR46","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1177\/1352458509105579","volume":"15","author":"BD Beretich","year":"2009","unstructured":"Beretich BD, Beretich TM. Explaining multiple sclerosis prevalence by ultraviolet exposure: a geospatial analysis. Mult Scler. 2009;15(8):891\u20138.","journal-title":"Mult Scler"},{"issue":"6","key":"380_CR47","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1212\/WNL.0b013e31820af93d","volume":"76","author":"RM Lucas","year":"2011","unstructured":"Lucas RM et al. Sun exposure and vitamin D are independent risk factors for CNS demyelination. Neurology. 2011;76(6):520\u201348.","journal-title":"Neurology"},{"issue":"1","key":"380_CR48","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000322512","volume":"36","author":"TY McDowell","year":"2011","unstructured":"McDowell TY et al. Sun exposure, vitamin D, and age at disease onset in relapsing multiple sclerosis. Neuroepidemiology. 2011;36(1):39\u201345.","journal-title":"Neuroepidemiology"},{"issue":"3","key":"380_CR49","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000122330","volume":"30","author":"MT Kampman","year":"2008","unstructured":"Kampman MT, Brustad M. Vitamin D: a candidate for the environmental effect in multiple sclerosis\u2014observations from Norway. Neuroepidemiology. 2008;30(3):140\u20136.","journal-title":"Neuroepidemiology"},{"issue":"2","key":"380_CR50","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1212\/01.wnl.0000316802.35974.34","volume":"71","author":"A Alonso","year":"2008","unstructured":"Alonso A, Hernan MA. Temporal trends in the incidence of multiple sclerosis: a systematic review. Neurology. 2008;71(2):129\u201335.","journal-title":"Neurology"},{"key":"380_CR51","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.neulet.2014.04.021","volume":"570","author":"S Duan","year":"2014","unstructured":"Duan S et al. Vitamin D status and the risk of multiple sclerosis: a systemic review and meta-analysis. Neurosci Lett. 2014;570:108\u201313.","journal-title":"Neurosci Lett"},{"issue":"23","key":"380_CR52","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1001\/jama.296.23.2832","volume":"296","author":"KL Munger","year":"2006","unstructured":"Munger KL et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA. 2006;296(23):2832\u20138.","journal-title":"JAMA"},{"issue":"5","key":"380_CR53","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/ana.21972","volume":"67","author":"EM Mowry","year":"2010","unstructured":"Mowry EM et al. Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis. Ann Neurol. 2010;67(5):618\u201324.","journal-title":"Ann Neurol"},{"issue":"3","key":"380_CR54","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1212\/WNL.0b013e31825fdec7","volume":"79","author":"TF Runia","year":"2012","unstructured":"Runia TF et al. Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis. Neurology. 2012;79(3):261\u20136.","journal-title":"Neurology"},{"issue":"2","key":"380_CR55","doi-asserted-by":"crossref","first-page":"193.203","DOI":"10.1002\/ana.22043","volume":"68","author":"S Simpson","year":"2010","unstructured":"Simpson S et al. Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis. Ann Neurol. 2010;68(2):193.203.","journal-title":"Ann Neurol"},{"issue":"5","key":"380_CR56","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00415-006-0315-8","volume":"254","author":"IA Mei Van der","year":"2007","unstructured":"Van der Mei IA et al. Vitamin D levels in people with multiple sclerosis and community controls in Tasmani. Aust J Neurol. 2007;254(5):581\u201390.","journal-title":"Aust J Neurol"},{"issue":"9","key":"380_CR57","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1177\/1352458508094399","volume":"14","author":"J Smolders","year":"2008","unstructured":"Smolders J et al. Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis. Mult Scler. 2008;14(9):1220\u20134.","journal-title":"Mult Scler"},{"issue":"2","key":"380_CR58","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/ana.23591","volume":"72","author":"EM Mowry","year":"2012","unstructured":"Mowry EM et al. Vitamin D status predicts new brain MRI activity in multiple sclerosis. Ann Neurol. 2012;72(2):234\u201340. This study demonstrated that serum vitamin D levels are inversely associated with the development of new T2-weighted lesions on MRI in patients with MS.","journal-title":"Ann Neurol"},{"issue":"2","key":"380_CR59","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/jnnp.2010.227942","volume":"82","author":"B Weinstock-Guttman","year":"2011","unstructured":"Weinstock-Guttman B et al. Vitamin D metabolites are associated with clinical and MRI outcomes in multiple sclerosis patients. J Neurol Neurosurg Psychiatry. 2011;82(2):189\u201395.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"380_CR60","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1212\/WNL.0b013e31825fded9","volume":"79","author":"N Stewart","year":"2012","unstructured":"Stewart N et al. Interferon- \u03b2 and serum 25-hydroxyvitamin D interact to modulate relapse risk in MS. Neurology. 2012;79(3):254\u201360.","journal-title":"Neurology"},{"issue":"6","key":"380_CR61","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S1474-4422(10)70086-7","volume":"9","author":"A Ascherio","year":"2010","unstructured":"Ascherio A, Munger KL, Simon KC. Vitamin D and multiple sclerosis. Lancet Neurol. 2010;9(6):599\u2013612.","journal-title":"Lancet Neurol"},{"issue":"4","key":"380_CR62","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.msard.2012.12.008","volume":"2","author":"A Ganesh","year":"2013","unstructured":"Ganesh A et al. The case for vitamin D supplementation in multiple sclerosis. Mult Scler Relat Disord. 2013;2(4):281\u2013306.","journal-title":"Mult Scler Relat Disord"},{"issue":"23","key":"380_CR63","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1212\/WNL.0b013e3181e1cec2","volume":"74","author":"JM Burton","year":"2010","unstructured":"Burton JM et al. A phase I\/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis. Neurology. 2010;74(23):1852\u20139.","journal-title":"Neurology"},{"issue":"5","key":"380_CR64","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/jnnp-2011-301876","volume":"83","author":"M Soilu-Hanninen","year":"2012","unstructured":"Soilu-Hanninen M et al. A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon \u03b2-1b in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry. 2012;83(5):565\u201371. This double-blind, placebo-controlled, randomized study demonstrated that patients with MS receiving vitamin D supplementation had fewer new T2-weighted lesions and a significantly lower number of T1 enhancing lesions as well as a tendency for reduced disability accumulation and improved timed tandem walk compared to controls not receiving vitamin D supplementation.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"380_CR65","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1136\/jnnp.2004.056499","volume":"76","author":"DM Wingerchuk","year":"2005","unstructured":"Wingerchuk DM et al. A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry. 2005;76(9):1294\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"380_CR66","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1177\/1756285612447090","volume":"5","author":"C Pierrot-Deseilligny","year":"2012","unstructured":"Pierrot-Deseilligny C et al. Relationship between 25-OH-D serum level and relapse rate in multiple sclerosis patients before and after vitamin D supplementation. Ther Adv Neurol Disord. 2012;5(4):187\u201398.","journal-title":"Ther Adv Neurol Disord"},{"issue":"12","key":"380_CR67","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1177\/1352458513489756","volume":"19","author":"E James","year":"2013","unstructured":"James E et al. The effect of vitamin D-related interventions on multiple sclerosis relapses: a meta-analysis. Mult Scler. 2013;19(12):1571\u20139.","journal-title":"Mult Scler"},{"issue":"6","key":"380_CR68","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3109\/08820139.2011.573041","volume":"40","author":"G Mosayebi","year":"2011","unstructured":"Mosayebi G et al. Therapeutic effect of vitamin D3 in multiple sclerosis patients. Immunol Investig. 2011;40(6):627\u201339.","journal-title":"Immunol Investig"},{"issue":"17","key":"380_CR69","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1212\/WNL.0b013e3182343274","volume":"77","author":"MS Stein","year":"2011","unstructured":"Stein MS et al. A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis. Neurology. 2011;77(17):1611\u20138.","journal-title":"Neurology"},{"issue":"8","key":"380_CR70","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1177\/1352458511434607","volume":"18","author":"MT Kampman","year":"2012","unstructured":"Kampman MT et al. Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial. Mult Scler. 2012;18(8):1144\u201351.","journal-title":"Mult Scler"},{"key":"380_CR71","first-page":"452541","volume":"2012","author":"V Shaygannejad","year":"2012","unstructured":"Shaygannejad V et al. Effects of adjunct low-dose vitamin D on relapsing-remitting multiple sclerosis progression: preliminary findings of a randomized placebo-controlled trial. Mult Scler Int. 2012;2012:452541.","journal-title":"Mult Scler Int"},{"issue":"3","key":"380_CR72","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000345122","volume":"40","author":"B Pozuelo-Moyano","year":"2013","unstructured":"Pozuelo-Moyano B et al. A systematic review of randomized, double-blind, placebo-controlled trials examining the clinical efficacy of vitamin D in multiple sclerosis. Neuroepidemiology. 2013;40(3):147\u201353.","journal-title":"Neuroepidemiology"},{"issue":"1-2","key":"380_CR73","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jns.2011.06.035","volume":"311","author":"EM Mowry","year":"2011","unstructured":"Mowry EM. Vitamin D: evidence for its role as a prognostic factor in multiple sclerosis. J Neurol Sci. 2011;311(1-2):19\u201322.","journal-title":"J Neurol Sci"},{"key":"380_CR74","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1212\/WNL.0b013e3181c7197b","volume":"74","author":"Y Slinin","year":"2010","unstructured":"Slinin Y et al. 25-Hydroxyvitamin D levels and cognitive performance and decline in elderly men. Neurology. 2010;74:33\u201341.","journal-title":"Neurology"},{"key":"380_CR75","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1159\/000356483","volume":"37","author":"C Annweiler","year":"2013","unstructured":"Annweiler C et al. Hypovitaminosis D and executive dysfunction in older adults with memory complaint: a memory clinic-based study. Dement Geriatr Cogn Disord. 2013;37:286\u201393.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"852","key":"380_CR76","first-page":"e859","volume":"14","author":"EM Brouwer-Brolsma","year":"2013","unstructured":"Brouwer-Brolsma EM et al. Serum 25-hydroxyvitamin D is associated with cognitive executive function in Dutch prefrail and frail elderly: a cross-sectional study exploring the associations of 25-hydroxyvitamin D with glucose metabolism, cognitive performance and depression. J Am Med Dir Assoc. 2013;14(852):e859\u2013817.","journal-title":"J Am Med Dir Assoc"},{"key":"380_CR77","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000334944","volume":"32","author":"C Annweiler","year":"2011","unstructured":"Annweiler C et al. Serum vitamin D deficiency as a predictor of incident non-Alzheimer dementias: a 7-year longitudinal study. Dement Geriatr Cogn Disord. 2011;32:273\u20138.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"380_CR78","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1212\/WNL.0b013e31826c197f","volume":"79","author":"C Balion","year":"2012","unstructured":"Balion C et al. Vitamin D, cognition, and dementia: a systematic review and meta-analysis. Neurology. 2012;79:1397\u2013405.","journal-title":"Neurology"},{"key":"380_CR79","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3233\/JAD-2012-121432","volume":"33","author":"C Annweiler","year":"2013","unstructured":"Annweiler C, Llewellyn DJ, Beauchet O. Low serum vitamin D concentrations in Alzheimer's disease: a systematic review and meta-analysis. J Alzheimers Dis. 2013;33:659\u201374.","journal-title":"J Alzheimers Dis"},{"key":"380_CR80","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1111\/jgs.13082","volume":"62","author":"CL Chei","year":"2014","unstructured":"Chei CL et al. Vitamin D levels and cognition in elderly adults in China. J Am Geriatr Soc. 2014;62:2125\u20139.","journal-title":"J Am Geriatr Soc"},{"key":"380_CR81","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1212\/WNL.0000000000000755","volume":"83","author":"TJ Littlejohns","year":"2014","unstructured":"Littlejohns TJ et al. Vitamin D and the risk of dementia and Alzheimer disease. Neurology. 2014;83:920\u20138. This large prospective cohort study showed that hypovitaminosis D resulted in a markedly increased risk of incident Alzheimer\u2019s disease and all-cause dementia.","journal-title":"Neurology"},{"key":"380_CR82","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1113\/jphysiol.2013.257527","volume":"592","author":"MJ Berridge","year":"2014","unstructured":"Berridge MJ. Calcium regulation of neural rhythms, memory and Alzheimer's disease. J Physiol. 2014;592:281\u201393.","journal-title":"J Physiol"},{"key":"380_CR83","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/cdd.2012.161","volume":"20","author":"M Moon","year":"2013","unstructured":"Moon M et al. Vitamin D-binding protein interacts with Abeta and suppresses Abeta-mediated pathology. Cell Death Differ. 2013;20:630\u20138.","journal-title":"Cell Death Differ"},{"key":"380_CR84","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.bcp.2013.12.018","volume":"88","author":"JE Morley","year":"2014","unstructured":"Morley JE, Farr SA. The role of amyloid-beta in the regulation of memory. Biochem Pharmacol. 2014;88:479\u201385.","journal-title":"Biochem Pharmacol"},{"key":"380_CR85","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3233\/JAD-140042","volume":"43","author":"RJ Bishnoi","year":"2015","unstructured":"Bishnoi RJ, Palmer RF, Royall DR. Vitamin D binding protein as a serum biomarker of Alzheimer's disease. J Alzheimers Dis. 2015;43:37\u201345.","journal-title":"J Alzheimers Dis"},{"key":"380_CR86","doi-asserted-by":"crossref","first-page":"e81989","DOI":"10.1371\/journal.pone.0081989","volume":"8","author":"P Johansson","year":"2013","unstructured":"Johansson P et al. Cerebrospinal fluid (CSF) 25-hydroxyvitamin D concentration and CSF acetylcholinesterase activity are reduced in patients with Alzheimer's disease. PLoS One. 2013;8:e81989.","journal-title":"PLoS One"},{"key":"380_CR87","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.3233\/JAD-141266","volume":"43","author":"J Muenchhoff","year":"2015","unstructured":"Muenchhoff J et al. Plasma protein profiling of mild cognitive impairment and Alzheimer's disease across two independent cohorts. J Alzheimers Dis. 2015;43:1355\u201373.","journal-title":"J Alzheimers Dis"},{"key":"380_CR88","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.exger.2015.06.012","volume":"69","author":"L Laczmanski","year":"2015","unstructured":"Laczmanski L et al. Vitamin D receptor gene polymorphisms in Alzheimer's disease patients. Exp Gerontol. 2015;69:142\u20137.","journal-title":"Exp Gerontol"},{"key":"380_CR89","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1532-5415.2011.03877.x","volume":"60","author":"C Annweiler","year":"2012","unstructured":"Annweiler C et al. Cognitive effects of vitamin D supplementation in older outpatients visiting a memory clinic: a pre-post study. J Am Geriatr Soc. 2012;60:793\u20135.","journal-title":"J Am Geriatr Soc"},{"key":"380_CR90","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1177\/1533317511424278","volume":"26","author":"MS Stein","year":"2011","unstructured":"Stein MS et al. A randomized controlled trial of high-dose vitamin D2 followed by intranasal insulin in Alzheimer's disease. J Alzheimers Dis. 2011;26:477\u201384.","journal-title":"J Alzheimers Dis"},{"key":"380_CR91","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1007\/s00198-008-0619-x","volume":"19","author":"R Przybelski","year":"2008","unstructured":"Przybelski R et al. Rapid correction of low vitamin D status in nursing home residents. Osteoporos Int. 2008;19:1621\u20138.","journal-title":"Osteoporos Int"},{"key":"380_CR92","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/joim.12279","volume":"277","author":"C Annweiler","year":"2014","unstructured":"Annweiler C et al. \u2018Vitamin D and cognition in older adults\u2019: updated international recommendations. J Intern Med. 2014;277:45\u201357.","journal-title":"J Intern Med"},{"key":"380_CR93","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1212\/WNL.0b013e3182a95818","volume":"81","author":"H Ding","year":"2013","unstructured":"Ding H et al. Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker Study. Neurology. 2013;81:1531\u20137.","journal-title":"Neurology"},{"key":"380_CR94","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/mds.25405","volume":"28","author":"AL Peterson","year":"2013","unstructured":"Peterson AL, Mancini M, Horak FB. The relationship between balance control and vitamin D in Parkinson's disease\u2014a pilot study. Mov Disord. 2013;28:1133\u20137.","journal-title":"Mov Disord"},{"key":"380_CR95","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1001\/archneur.65.10.1348","volume":"65","author":"ML Evatt","year":"2008","unstructured":"Evatt ML et al. Prevalence of vitamin d insufficiency in patients with Parkinson disease and Alzheimer disease. Arch Neurol. 2008;65:1348\u201352.","journal-title":"Arch Neurol"},{"key":"380_CR96","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/mds.24016","volume":"27","author":"M Suzuki","year":"2012","unstructured":"Suzuki M et al. 25-Hydroxyvitamin D, vitamin D receptor gene polymorphisms, and severity of Parkinson's disease. Mov Disord. 2012;27:264\u201371.","journal-title":"Mov Disord"},{"key":"380_CR97","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1212\/01.wnl.0000257089.50476.92","volume":"68","author":"Y Sato","year":"2007","unstructured":"Sato Y, Honda Y, Iwamoto J. Risedronate and ergocalciferol prevent hip fracture in elderly men with Parkinson disease. Neurology. 2007;68:911\u20135.","journal-title":"Neurology"},{"key":"380_CR98","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s11064-006-9048-4","volume":"31","author":"MP Smith","year":"2006","unstructured":"Smith MP et al. Calcitriol protection against dopamine loss induced by intracerebroventricular administration of 6-hydroxydopamine. Neurochem Res. 2006;31:533\u20139.","journal-title":"Neurochem Res"},{"key":"380_CR99","doi-asserted-by":"crossref","unstructured":"Kim JS et al. 1alpha,25-Dihydroxyvitamin D(3) Protects dopaminergic neurons in rodent models of Parkinson\u2019s disease through inhibition of microglial activation. J Clin Neurol. 2006;2:252\u20137.","DOI":"10.3988\/jcn.2006.2.4.252"},{"key":"380_CR100","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0006-8993(01)02450-7","volume":"904","author":"JY Wang","year":"2001","unstructured":"Wang JY et al. Vitamin D(3) attenuates 6-hydroxydopamine-induced neurotoxicity in rats. Brain Res. 2001;904:67\u201375.","journal-title":"Brain Res"},{"key":"380_CR101","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1469-1809.2010.00631.x","volume":"75","author":"MW Butler","year":"2011","unstructured":"Butler MW et al. Vitamin D receptor gene as a candidate gene for Parkinson disease. Ann Hum Genet. 2011;75:201\u201310.","journal-title":"Ann Hum Genet"},{"key":"380_CR102","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neulet.2013.07.014","volume":"551","author":"R Torok","year":"2013","unstructured":"Torok R et al. Association of vitamin D receptor gene polymorphisms and Parkinson's disease in Hungarians. Neurosci Lett. 2013;551:70\u20134.","journal-title":"Neurosci Lett"},{"key":"380_CR103","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s10072-014-1868-4","volume":"35","author":"YH Lee","year":"2014","unstructured":"Lee YH, Kim JH, Song GG. Vitamin D receptor polymorphisms and susceptibility to Parkinson's disease and Alzheimer's disease: a meta-analysis. Neurol Sci. 2014;35:1947\u201353.","journal-title":"Neurol Sci"},{"key":"380_CR104","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.neulet.2014.06.051","volume":"578","author":"ZT Zhang","year":"2014","unstructured":"Zhang ZT et al. Association between vitamin D receptor gene polymorphisms and susceptibility to Parkinson's disease: a meta-analysis. Neurosci Lett. 2014;578:122\u20137.","journal-title":"Neurosci Lett"},{"key":"380_CR105","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.neurobiolaging.2013.11.005","volume":"35","author":"W Camu","year":"2014","unstructured":"Camu W et al. Vitamin D confers protection to motoneurons and is a prognostic factor of amyotrophic lateral sclerosis. Neurobiol Aging. 2014;35:1198\u2013205. This study showed that lower levels of vitamin D correlated with faster functional decline in ALS patients, even after excluding non-ambulatory patients.","journal-title":"Neurobiol Aging"},{"issue":"8","key":"380_CR106","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/cns.12423","volume":"21","author":"H Blasco","year":"2015","unstructured":"Blasco H et al. Vitamin D is not a protective factor in ALS. CNS Neurosci Ther. 2015;21(8):651\u20136.","journal-title":"CNS Neurosci Ther"},{"key":"380_CR107","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.jocn.2013.01.011","volume":"20","author":"C Karam","year":"2013","unstructured":"Karam C et al. Vitamin D deficiency and its supplementation in patients with amyotrophic lateral sclerosis. J Clin Neurosci. 2013;20:1550\u20133.","journal-title":"J Clin Neurosci"},{"key":"380_CR108","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1161\/CIRCOUTCOMES.112.967604","volume":"5","author":"L Wang","year":"2012","unstructured":"Wang L et al. Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes. 2012;5:819\u201329.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"380_CR109","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/ene.12731","volume":"22","author":"AL Schneider","year":"2015","unstructured":"Schneider AL et al. Vitamin D, vitamin D binding protein gene polymorphisms, race and risk of incident stroke: the Atherosclerosis Risk in Communities (ARIC) study. Eur J Neurol. 2015;22:1220\u20137.","journal-title":"Eur J Neurol"},{"key":"380_CR110","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ana.23738","volume":"73","author":"P Brondum-Jacobsen","year":"2013","unstructured":"Brondum-Jacobsen P et al. 25-Hydroxyvitamin D and symptomatic ischemic stroke: an original study and meta-analysis. Ann Neurol. 2013;73:38\u201347.","journal-title":"Ann Neurol"},{"key":"380_CR111","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s10654-012-9729-z","volume":"27","author":"R Chowdhury","year":"2012","unstructured":"Chowdhury R et al. Circulating vitamin D, calcium and risk of cerebrovascular disease: a systematic review and meta-analysis. Eur J Epidemiol. 2012;27:581\u201391.","journal-title":"Eur J Epidemiol"},{"key":"380_CR112","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/aje\/kwu059","volume":"179","author":"CC Welles","year":"2014","unstructured":"Welles CC et al. Vitamin D deficiency and cardiovascular events in patients with coronary heart disease: data from the heart and soul Study. Am J Epidemiol. 2014;179:1279\u201387.","journal-title":"Am J Epidemiol"},{"key":"380_CR113","doi-asserted-by":"crossref","first-page":"521","DOI":"10.2337\/dc14-0180","volume":"38","author":"M Herrmann","year":"2015","unstructured":"Herrmann M et al. Serum 25-hydroxyvitamin D: a predictor of macrovascular and microvascular complications in patients with type 2 diabetes. Diabetes Care. 2015;38:521\u20138.","journal-title":"Diabetes Care"},{"key":"380_CR114","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1161\/STROKEAHA.114.007706","volume":"46","author":"PW Chung","year":"2015","unstructured":"Chung PW et al. 25-Hydroxyvitamin D status is associated with chronic cerebral small vessel disease. Stroke. 2015;46:248\u201351.","journal-title":"Stroke"},{"key":"380_CR115","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/jamaneurol.2014.755","volume":"71","author":"ED Michos","year":"2014","unstructured":"Michos ED et al. Vitamin D and subclinical cerebrovascular disease: the atherosclerosis risk in communities brain magnetic resonance imaging study. JAMA Neurol. 2014;71:863\u201371.","journal-title":"JAMA Neurol"},{"key":"380_CR116","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.03.007","volume":"24","author":"SA Yalbuzdag","year":"2015","unstructured":"Yalbuzdag SA et al. Is 25(OH)D associated with cognitive impairment and functional improvement in stroke? A retrospective clinical study. J Stroke Cerebrovasc Dis. 2015;24:1479\u201386.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"9","key":"380_CR117","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/ene.12607","volume":"22","author":"B Han","year":"2015","unstructured":"Han B et al. Low serum levels of vitamin D are associated with post-stroke depression. Eur J Neurol. 2015;22(9):1269\u201374.","journal-title":"Eur J Neurol"},{"key":"380_CR118","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.03.051","volume":"24","author":"A Turetsky","year":"2015","unstructured":"Turetsky A, Goddeau Jr RP, Henninger N. Low serum vitamin D is independently associated with larger lesion volumes after ischemic stroke. J Stroke Cerebrovasc Dis. 2015;24:1555\u201363.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"380_CR119","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1159\/000362534","volume":"37","author":"B Daubail","year":"2014","unstructured":"Daubail B et al. Association between serum concentration of vitamin D and 1-year mortality in stroke patients. Cerebrovasc Dis. 2014;37:364\u20137.","journal-title":"Cerebrovasc Dis"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-015-0380-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-015-0380-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-015-0380-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T08:51:51Z","timestamp":1748681511000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-015-0380-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,4]]},"references-count":119,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["380"],"URL":"https:\/\/doi.org\/10.1007\/s11940-015-0380-3","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,4]]},"article-number":"51"}}